Skip to content
10-K

Annual Report

AOXING PHARMACEUTICAL COMPANY, INC.

0001096906-15-001048

← back to feed
Filed
Oct 13, 2015 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2015 · Oct 9, 2015 72.17M sh
Capex FY 2015 · Jun 30, 2014 $268.92K
Operating Cash Flow FY 2015 · Jun 30, 2014 −$7.73M
Short Term Debt FY 2015 · Jun 30, 2014 $11.4M
Stockholders Equity FY 2015 · Jun 30, 2014 −$2.51M
Current Liabilities FY 2015 · Jun 30, 2014 $34.21M
Current Assets FY 2015 · Jun 30, 2014 $10.92M
Total Assets FY 2015 · Jun 30, 2014 $38.07M
Sga Expense FY 2015 · Jun 30, 2014 $3.61M
Rd Expense FY 2015 · Jun 30, 2014 $569.7K
Net Income FY 2015 · Jun 30, 2014 −$8.63M
Operating Income FY 2015 · Jun 30, 2014 −$3.33M
Gross Profit FY 2015 · Jun 30, 2014 $5.81M
Cost Of Revenue FY 2015 · Jun 30, 2014 $6.93M